Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENAbLE-Sweden. Secondary Prevention of Stroke: Mobile Health to Promote Physical Activity in People Post Stroke or Transient Ischemic Attack

NCT05111951 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05111951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05111951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENAbLE-Sweden. Secondary Prevention of Stroke: Mobile Health to Promote Physical Activity in People Post Stroke or Transient Ischemic Attack
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2021
Completion date
December 22, 2023
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, transient ischemic attack